Mumbai, India has emerged as a significant hub for the manufacture of Acalabrutinib Active Pharmaceutical Ingredient (API), with several companies excelling at its synthesis . Notably, a few manufacturers in this region are recognized for their high-quality Acalabrutinib (CAS 1420477-60-6) produc